Wezenla
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Wezenla, covering 2026-02-18 to 2026-07-01. Get the full timeline:
Most recent: EMA Authorised: Wezenla (ustekinumab) — Amgen Technology (Ireland) UC